Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Study Finds Benzoyl Peroxide for Acne Does Not Increase Cancer Risk or Significant Benzene Exposure
Description
The presenter describes a study assessing whether benzoyl peroxide, a common acne treatment, is associated with cancer risk or meaningful benzene exposure after public concern arose in 2024 about possible benzene contamination. Using a matched retrospective cohort from the TriNetX database, the researchers compared acne patients treated with benzoyl peroxide to matched controls and found no significant increase over 10 years in lymphoma, leukemia, or other internal/solid organ cancers. They also analyzed national survey data and found no higher blood benzene levels in people using benzoyl peroxide. The findings are reassuring for patients and clinicians, suggesting benzoyl peroxide does not appear to cause clinically meaningful benzene exposure or increased cancer risk, though the speaker notes limitations such as possible misclassification, lack of product-level data, and no dose-response analysis, and calls for future prospective studies.
Conclusions
- The study found no significant increase in cancer risk among acne patients treated with benzoyl peroxide over 10 years.
- Benzoyl peroxide use was not associated with higher risks of lymphoma, leukemia, or internal/solid organ malignancies.
- Measured blood benzene levels were not higher in people using benzoyl peroxide than in nonusers.
- Any benzene present in benzoyl peroxide products appeared unlikely to pose a clinically meaningful risk.
- Overall, the findings are reassuring for routine clinical use of benzoyl peroxide in acne treatment.
- The results support shared decision-making and may help reduce public concern about benzoyl peroxide safety.
- Despite reassuring findings, the presenter recommends pragmatic efforts to reduce or eliminate benzene contamination in benzoyl peroxide products.
- The conclusions are limited by possible misclassification, lack of product-level data, and inability to assess dose-response relationships.
- Further prospective studies are still needed to confirm benzoyl peroxide safety.
- Benzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: A retrospective cohort study#10.1016/j.jaad.2024.07.011